The Cell Culture & Upstream Processing Track will feature process development scientists, engineers and technical experts sharing their recent achievements in reducing timelines and cost of goods while increasing efficiency and productivity through implementation of disruptive approaches and technologies.
Development of a Scaleable and Productive Insect Cell Culture Based Process for Making Flublok, The First FDA Licensed Recombinant Influenza Vaccine
Barry Buckland, Senior Advisor, Protein Sciences
Full Presentation: 11:30 am, Weds., Oct. 28, 2015
Hear from Barry Buckland about the journey to the manufacture of the first recombinant influenza vaccine. The vaccine is manufactured using a the bacculovirus expression system and insect cell culture, that can be scaled up to large volumes for seasonal or pandemic influenza.
Please log in to access this content.
Modeling of Glycosylation – Predicting Profiles of Glycosylation from Metabolic Data
Michael Butler, Professor, University of Manitoba
Full Presentation: 1:30 pm, Tuesday, Oct. 27, 2015
This podcast previews three methods to control glycosylation. Professor Butler describes the work of the INSERC Strategic Network for Production of Single-Type Glycoform Monoclonal Antibodies, including the tools and methods used in the study.
Please log in to access this content.
High-Throughput Multi-Parametric Clone Screening Approach for the Generation of Tailored Production Cell Lines
Trent Munro, Principal Scientist, Amgen
Full Presentation: 8:05 am, Tuesday, Oct. 27, 2015
In his talk, Munro will share the methods Amgen has developed and techniques for increasing throughput for cell line development. In this podcast he describes the parameters and process behind this work.
Please log in to access this content.
View the complete Cell Culture & Upstream Processing
speaker line-up.